Federal Telehealth Laws: DEA, Medicare, HIPAA and More
How federal law shapes U.S. telehealth: DEA controlled-substance prescribing, Medicare and Medicaid coverage, HIPAA, fraud and abuse, and FDA device rules.
Table of contents
- Who Regulates Telehealth?
- Can Controlled Substances Be Prescribed Through Telehealth?
- Medicare Telehealth Rules
- Medicaid Telehealth Rules
- HIPAA and Telehealth
- Audio-Only Telehealth
- Fraud, Kickbacks and Telehealth
- FDA Rules for Telehealth Technology
- Can a U.S. Doctor Treat a Patient Who Is Overseas?
- A Practical Telehealth Compliance Checklist
- The Bottom Line
- Related TeleMed Today Resources
- Frequently asked questions
Telehealth may happen through a screen, but the law still starts with a physical place. Where is the patient sitting during the appointment? That is one of the most important questions in U.S. telehealth law.
If a doctor is sitting in New York and the patient is sitting in Florida, the doctor is generally practicing medicine in Florida. Florida's licensing and medical-practice rules therefore matter even though the physician never crossed the state line.
Federal law is then layered on top. Medicare has its own telehealth coverage rules. The DEA regulates controlled-substance prescribing. HIPAA governs protected health information for covered entities and business associates. The FDA can regulate certain remote-monitoring devices and medical software. Federal fraud-and-abuse laws govern financial arrangements surrounding the care.
That gives telehealth providers a useful way to think about compliance. State law generally determines whether and how you can treat the patient. Federal law adds rules governing areas such as payment, privacy, controlled substances, devices, and healthcare business arrangements. A telehealth provider usually has to satisfy both.
This guide covers the federal layer. For the state layer (licensure, standard of care, consent and most prescribing rules), see our explainer on how state telemedicine laws work, and compare individual states in the state law comparison table.
TeleMed Today provides independent educational information about telemedicine, digital health and healthcare policy. This page is not legal, medical or billing advice, and telehealth requirements change frequently — verify current rules with the relevant licensing board, CMS, DEA, payer or qualified professional before acting.
Who Regulates Telehealth?
There is no single federal "telehealth license" or one national telemedicine law that replaces state medical regulation. Different questions are controlled by different authorities.
| Question | Primary Authority |
|---|---|
| Can this clinician treat this patient? | State licensing law |
| What standard of care applies? | State law and licensing boards |
| Is telehealth consent required? | State law and sometimes payer rules |
| Can a medication be prescribed? | State law; DEA rules also apply to controlled substances |
| Will Medicare pay for the visit? | CMS and federal law |
| Will Medicaid pay? | State Medicaid program and federal requirements |
| How must protected health information be handled? | HIPAA plus applicable state privacy laws |
| Is a remote-monitoring device regulated? | FDA |
| Can a non-physician company employ physicians? | State corporate-practice rules |
| Are referral and compensation arrangements legal? | Federal and state fraud-and-abuse laws |
This is why asking whether something is simply "legal under telehealth law" usually does not produce a complete answer. You first have to know which part of telehealth law you are talking about. The state rows in that table (licensure, standard of care, consent, most prescribing rules and corporate-practice limits) are covered in our explainer on how state telemedicine laws work. The rest of this guide covers the federal rows.
Can Controlled Substances Be Prescribed Through Telehealth?
Federal controlled-substance prescribing is governed in part by the Ryan Haight Online Pharmacy Consumer Protection Act and DEA rules. Historically, the Ryan Haight framework generally required an in-person medical evaluation before certain controlled substances could be prescribed over the internet unless an exception applied. The COVID-19 public health emergency produced major temporary telemedicine exceptions, and those rules have continued to evolve.
Current Federal Status
DEA and HHS have extended the pandemic-era telemedicine prescribing flexibilities through December 31, 2026. Under that extension (90 FR 61301), a DEA-registered practitioner may prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter without having previously conducted an in-person medical evaluation, when the applicable conditions are satisfied. Audio-only encounters qualify only for Schedule III–V narcotic medications approved by the FDA to treat opioid use disorder, such as buprenorphine.
DEA has also adopted two permanent rules, in effect since December 31, 2025. Under 21 CFR 1306.51, a practitioner who first reviews the patient's state prescription drug monitoring program data may prescribe buprenorphine and other FDA-approved Schedule III–V medications for opioid use disorder after a telemedicine encounter, including audio-only, for up to six calendar months from the first prescription. Further prescriptions then require at least one in-person medical evaluation, as defined in 21 U.S.C. 829(e)(2)(B), or another pathway authorized by 21 U.S.C. 829(e), such as another form of telemedicine allowed under federal law. A separate rule, 21 CFR 1306.52, covers continuity of care for VA patients.
December 31, 2026 is an important date to verify rather than permanently hard-code into a compliance program.
State law may also be more restrictive than federal law, and a prescription must satisfy both. Providers should verify the latest guidance directly with the DEA before prescribing controlled substances through telehealth. This is especially important for organizations providing:
- Psychiatry
- ADHD treatment
- Addiction treatment
- Buprenorphine treatment
- Pain management
- Other services involving controlled medications
A telehealth article written six months ago can already be outdated in this area.
Medicare Telehealth Rules
Medicare telehealth policy changed dramatically during the COVID-19 pandemic and has continued changing through subsequent legislation and CMS rulemaking. Many Medicare telehealth flexibilities have been extended through December 31, 2027. Among the currently extended policies, Medicare patients can receive many non-behavioral health telehealth services from home without the old geographic originating-site restrictions through the end of 2027, and certain eligible practitioners can continue providing those services through that period as well.
Some behavioral-health telehealth changes have been made permanent, although CMS says an in-person visit requirement for mental health telehealth at home takes effect after December 31, 2027.
Telehealth legality and telehealth reimbursement are not the same question. A provider can be legally permitted to treat a patient and still find that a particular payer will not reimburse the encounter. Conversely, a service appearing on a payer's telehealth coverage list does not eliminate state licensing requirements. For a deeper explanation, see Telehealth Reimbursement.
Medicaid Telehealth Rules
Medicaid adds another layer because programs are administered by individual states within the federal Medicaid framework. Policies can differ regarding:
- Covered services
- Eligible practitioners
- Patient location
- Provider location
- Audio-only care
- Behavioral health
- Remote patient monitoring
- Billing codes
- Documentation
- Payment rates
Providers operating nationally therefore have to keep state medical law, Medicare rules, Medicaid rules and commercial payer policies separate. They are related, but they are not interchangeable.
HIPAA and Telehealth
HIPAA does not disappear because the appointment takes place over video. Covered healthcare providers and health plans must comply with applicable HIPAA requirements when providing telehealth, which includes protecting patients' protected health information and using appropriate safeguards.
Where a technology company handles protected health information on behalf of a covered provider and qualifies as a business associate, the relationship will generally require an appropriate Business Associate Agreement, or BAA. Providers should evaluate more than whether a product advertises itself as "HIPAA compliant." Look at:
- How information is transmitted
- Where information is stored
- Access controls
- Authentication
- Encryption
- Logging
- Data retention
- Vendor access
- Breach procedures
- Business associate agreements
- Patient communications
- Recording settings
State privacy laws may impose additional requirements, including on health information that falls outside traditional HIPAA relationships. Read our full guide to Telehealth Security and HIPAA.
Audio-Only Telehealth
A phone call can qualify as telehealth in some circumstances, but audio-only treatment is not universally interchangeable with video. The answer can depend on:
- The state
- The specialty
- The clinical service
- The payer
- The patient's circumstances
- Whether the service can safely be provided without visual information
HIPAA does not categorically prohibit audio-only telehealth. HHS has specifically addressed how covered entities can provide audio-only telehealth while complying with applicable HIPAA requirements. The larger question is often whether the particular service can legally, clinically and financially be delivered that way.
Fraud, Kickbacks and Telehealth
Telehealth operates within the same federal fraud-and-abuse framework as the rest of healthcare. The Anti-Kickback Statute, Stark Law, False Claims Act and related rules can apply to telehealth business arrangements. Risk can arise when compensation is connected to:
- Referrals
- Prescription volume
- Testing orders
- Medical equipment orders
- Medicare business
- Lead generation
- Patient recruitment
- Financial relationships with referral sources
Federal enforcement agencies have pursued large fraud cases in which telemarketing operations used brief or nonexistent telehealth encounters to generate reimbursable prescriptions, tests or medical-equipment orders. That is different from legitimate telemedicine, but legitimate telehealth companies should understand why these structures receive scrutiny. A telehealth encounter should be driven by a genuine clinical relationship and medical need, not by the financial value of whatever can be ordered afterward.
FDA Rules for Telehealth Technology
Most ordinary video-conferencing technology is not regulated as a medical device simply because doctors use it. Some technologies used within telehealth are. FDA oversight may become relevant for:
- Connected diagnostic devices
- Remote monitoring hardware
- Certain clinical decision-support software
- Software intended to diagnose disease
- Some AI-enabled medical tools
- Software as a Medical Device, or SaMD
The distinction often depends on the product's intended use and the claims made about what it does. That question comes up more often as telehealth moves beyond video visits into continuous monitoring, artificial intelligence and home-based diagnostics. Read more in our guide to Remote Patient Monitoring.
Can a U.S. Doctor Treat a Patient Who Is Overseas?
Telehealth technology works almost anywhere. Medical licenses generally do not. A U.S. physician's state license does not automatically authorize that physician to practice medicine on a patient physically located in another country. The destination country's laws matter, and there may also be issues involving:
- Malpractice insurance
- Privacy law
- Data transfers
- Prescriptions
- Medication availability
- Emergency response
- Professional registration
The same logic applies in reverse. A physician located abroad generally cannot treat a patient physically located in a U.S. state simply because the interaction occurs online. The physician typically still needs authority to practice in the patient's state. For a broader look, see Telemedicine Around the World.
A Practical Telehealth Compliance Checklist
Before providing a telehealth encounter, a practice should be able to answer these questions.
Where is the patient? Confirm the patient's physical location.
Can the clinician practice there? Verify the relevant license, compact privilege, registration or exemption.
Can this service be delivered remotely? Consider state rules, modality requirements and standard of care.
Has the patient provided any required telehealth consent? Document it appropriately.
Can this medication be prescribed? Check state law and, for controlled substances, current DEA requirements.
Is the technology appropriate? Evaluate HIPAA, security, privacy and clinical limitations.
Will the payer cover it? Check Medicare, Medicaid or commercial payer requirements separately.
What happens if the patient needs in-person or emergency care? Have an escalation procedure before the appointment begins.
That framework will answer far more compliance questions than simply asking whether "telehealth is legal."
The Bottom Line
There is no single telehealth law in the United States. There is a stack of laws. State law usually starts with the patient's physical location and determines who may practice, what standard of care applies and what consent or prescribing rules must be followed. Federal law then adds rules involving Medicare, controlled substances, HIPAA, medical devices, fraud and other areas.
For providers, one question should come before almost everything else: Where is the patient right now? Once you know that, you can determine which state's rules apply and then layer the appropriate federal and payer requirements on top.
The underlying structure of telehealth law is relatively straightforward. The details change constantly, which is why good telehealth compliance is not a policy you write once. It is a system you keep current.
Related TeleMed Today Resources
Frequently asked questions
- Is there a federal telehealth license?
- No. There is no federal telehealth license. Authority to treat a patient generally comes from the state where the patient is physically located during the encounter. Federal law adds rules for payment, controlled substances, privacy, medical devices and healthcare business arrangements.
- Can doctors prescribe controlled substances through telehealth in 2026?
- Yes. Under the temporary rule DEA and HHS published December 31, 2025 (90 FR 61301), DEA-registered practitioners can prescribe Schedule II–V controlled substances after a real-time audio-video telemedicine encounter, without a prior in-person evaluation, through December 31, 2026. Audio-only visits qualify only for Schedule III–V narcotic medications approved to treat opioid use disorder. The rule's other requirements and state law still apply.
- How long are Medicare telehealth flexibilities extended?
- Many Medicare telehealth flexibilities are extended through December 31, 2027. Some behavioral-health telehealth policies are permanent, but CMS says an in-person visit requirement for mental health telehealth at home takes effect after December 31, 2027. Providers should check the current CMS requirements for the particular service being billed.
- Does HIPAA apply to telehealth?
- Yes. HIPAA-covered providers and health plans remain subject to applicable HIPAA requirements when providing telehealth. Providers should evaluate the technology, privacy safeguards, vendor relationships and business associate agreements involved.
- Can telehealth be audio-only?
- Sometimes. Federal programs, states and payers differ on when audio-only services are permitted or reimbursable. The provider must also determine whether audio-only care satisfies the applicable clinical standard of care.
- Can a doctor treat a patient in another country using telehealth?
- A U.S. medical license alone generally does not create authority to practice medicine in another country. Providers must consider the laws of the country where the patient is located along with malpractice, privacy, prescribing and other requirements.
Sources & further reading
- DEA/HHS — Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities, 90 FR 61301
- CMS — Telehealth FAQ (updated February 26, 2026)
- HHS OCR — HIPAA and audio-only telehealth guidance
- HHS Office for Civil Rights — HIPAA
- HHS Telehealth Resource Hub
- Center for Connected Health Policy
- U.S. Food and Drug Administration
- Centers for Medicare & Medicaid Services
- Drug Enforcement Administration